BioNTech's China partner lets mainland Chinese book mRNA COVID shots in HK
Published
BioNTech SE’s Chinese partner has started allowing mainland Chinese to register for its mRNA COVID-19 vaccine in Hong Kong ahead of a border reopening early next month that may spark a wave of visitors to the financial hub. Shanghai Fosun Pharmaceutical Group Co. is letting people register for the…
#mrna #taiwan #macau #fosunpharm #olafscholzs #hongkong